Institutional investors hold a majority ownership of HPTX through the 51.02% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2014, these large investors purchased a net $717.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TFS CAPITAL LLC Bought 39.4 Thousand shares of Hyperion Therapeutics Inc
SMITH ASSET MANAGEMENT GROUP LP Bought 32.1 Thousand shares of Hyperion Therapeutics Inc